Trilogy Capital »

Medifast shares owned by Trilogy Capital

Quarter-by-quarter ownership of Medifast (MED) shares owned by Trilogy Capital from 13F filings

Historical chart of Trilogy Capital investment in Medifast

Tip: Access up to 7 years of quarterly data

All positions including Medifast held by Trilogy Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Medifast by Trilogy Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $223k 3.0k 74.85
2023-06-30 $309k 3.3k 93.83
2023-03-31 $290k 2.8k 103.68
2022-12-31 $203k 1.8k 115.33

More positions owned by Trilogy Capital

Vanguard Index Fds Total Stk Mkt (VTI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Wisdomtree Tr Us Largecap Divd (DLN)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Select Sector Spdr Tr State Street Tec (XLK)
Wisdomtree Tr Emgring Mkts (EMMF)
Spdr Series Trust State Street Spd (SPAB)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Select Sector Spdr Tr State Street Ind (XLI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p Mcp Etf (IJH)
Alps Etf Tr Smith Core Plus (SMTH)
First Tr Exchng Traded Fd Vi Smith Unconstrai (UCON)
Ishares Tr Core S&p Scp Etf (IJR)

View all positions for Trilogy Capital

Top funds holding Medifast

BlackRock
Renaissance Technologies
Vanguard Group
Susquehanna International
Charles Schwab Investment Management
Jane Street
Peak6
Acadian Asset Management
Lido Advisors
AQR Capital Management
Dimensional Fund Advisors
D. E. Shaw & Co
Citadel Advisors
Geode Capital Management
Two Sigma Investments

View all funds holding Medifast